Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methods to study postprandial lipemia.
Ooi TC, Nordestgaard BG. Ooi TC, et al. Curr Vasc Pharmacol. 2011 May;9(3):302-8. doi: 10.2174/157016111795495567. Curr Vasc Pharmacol. 2011. PMID: 21314627 Review.
Postprandial lipaemia and vascular disease.
Kolovou G, Ooi TC. Kolovou G, et al. Among authors: ooi tc. Curr Opin Cardiol. 2013 Jul;28(4):446-51. doi: 10.1097/HCO.0b013e3283606971. Curr Opin Cardiol. 2013. PMID: 23591556 Review.
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text.
Kolovou GD, Watts GF, Mikhailidis DP, Pérez-Martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J, Tybjærg-Hansen A, Tentolouris N, Nordestgaard BG. Kolovou GD, et al. Among authors: ooi tc. Curr Vasc Pharmacol. 2019;17(5):498-514. doi: 10.2174/1570161117666190507110519. Curr Vasc Pharmacol. 2019. PMID: 31060488 Review.
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review.
Kolovou GD, Watts GF, Mikhailidis DP, Pérez-Martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J, Tybjærg-Hansen A, Tentolouris N, Nordestgaard BG. Kolovou GD, et al. Among authors: ooi tc. Curr Vasc Pharmacol. 2019;17(5):515-537. doi: 10.2174/1570161117666190503123911. Curr Vasc Pharmacol. 2019. PMID: 31309820 Review.
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement.
Kolovou GD, Watts GF, Mikhailidis DP, Pérez-Martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J, Tybjærg-Hansen A, Tentolouris N, Nordestgaard BG. Kolovou GD, et al. Among authors: ooi tc. Curr Vasc Pharmacol. 2019;17(5):538-540. doi: 10.2174/1570161117999190517115432. Curr Vasc Pharmacol. 2019. PMID: 31418346 Free article. Review.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
132 results